Leirdal M, Sioud M
Institute for Cancer Research, Department of Immunology, The Norwegian Radium Hospital, Oslo.
Br J Cancer. 1999 Jul;80(10):1558-64. doi: 10.1038/sj.bjc.6690560.
Although protein kinase C has been shown to be involved in a wide range of biological functions, the precise role of each isoform in a specific cell function remains to be clarified. Here we demonstrate that a ribozyme specific for the human protein kinase C alpha (PKC alpha), a classical PKC isoform, induces cell death in glioma cell lines. This cell death was identified as apoptosis by morphologic alterations and endonucleosomal DNA fragmentation. The inhibition of PKC alpha gene expression by the ribozyme resulted in a significant reduction in Bcl-xL gene expression, a protein that inhibits apoptosis and is overexpressed in glioma cells. Taken together, our data suggest that the PKC alpha ribozymes are a potent inducer of apoptosis in glioma cells, which may act through suppressing Bcl-xL gene expression and/or activity. PKC alpha ribozymes may prove useful in the management of malignant gliomas.
尽管蛋白激酶C已被证明参与多种生物学功能,但每种同工型在特定细胞功能中的精确作用仍有待阐明。在此我们证明,一种针对人蛋白激酶Cα(PKCα)(一种经典的PKC同工型)的核酶可诱导胶质瘤细胞系发生细胞死亡。通过形态学改变和核小体间DNA片段化,这种细胞死亡被鉴定为凋亡。核酶对PKCα基因表达的抑制导致Bcl-xL基因表达显著降低,Bcl-xL是一种抑制凋亡且在胶质瘤细胞中过表达的蛋白质。综上所述,我们的数据表明PKCα核酶是胶质瘤细胞凋亡的有效诱导剂,其可能通过抑制Bcl-xL基因表达和/或活性发挥作用。PKCα核酶可能在恶性胶质瘤的治疗中证明是有用的。